Human antibody responses to mature and immature forms of viral envelope inrespiratory syncytial virus infection: Significance for subunit vaccines

Citation
H. Sakurai et al., Human antibody responses to mature and immature forms of viral envelope inrespiratory syncytial virus infection: Significance for subunit vaccines, J VIROLOGY, 73(4), 1999, pp. 2956-2962
Citations number
41
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGY
ISSN journal
0022538X → ACNP
Volume
73
Issue
4
Year of publication
1999
Pages
2956 - 2962
Database
ISI
SICI code
0022-538X(199904)73:4<2956:HARTMA>2.0.ZU;2-C
Abstract
A number of antibodies generated during human respiratory syncytial virus ( RSV) infection have been cloned by the phage library approach. Antibodies r eactive with an immunodominant epitope on the F glycoprotein of this virus have a high affinity for affinity-purified F antigen. These antibodies, how ever, have a much lower affinity for mature F glycoprotein on the surface o f infected cells and are nonneutralizing. In contrast, a patent neutralizin g antibody has a high affinity for mature F protein but a much lower affini ty for purified F protein or F protein in viral lysates. The data indicate that at least two F protein immunogens are produced during natural RSV infe ction: immature F, found in viral lysates, and mature F, found on infected cells or virions. Binding studies with polyclonal human immunoglobulin G su ggest that the antibody responses to the two immunogens are of similar magn itudes. Competitive binding studies suggest that overlap between the respon ses is relatively limited. A mature envelope with an antigenic configuratio n different from that of the immature envelope has an evolutionary advantag e in that the infecting virus is less subject to neutralization by the humo ral response to the immature envelope that inevitably arises following lysi s of infected cells. Subunit vaccines may be at a disadvantage because they most often resemble immature envelope molecules and ignore this aspect of viral evasion.